RENDERED: SEPTEMBER 5, 2025; 10:00 A.M. NOT TO BE PUBLISHED
Commonwealth of Kentucky Court of Appeals NO. 2024-CA-1304-MR
MARION GAIL SMITH APPELLANT
APPEAL FROM FAYETTE CIRCUIT COURT v. HONORABLE KIMBERLY N. BUNNELL, JUDGE ACTION NO. 22-CI-01381
BELINDA L. SHIRKEY, M.D. AND RETINA AND VITREOUS ASSOCIATES OF KENTUCKY, PLLC D/B/A RETINA ASSOCIATES OF KENTUCKY APPELLEES
OPINION AFFIRMING
** ** ** ** **
BEFORE: THOMPSON, CHIEF JUDGE; ACREE AND MOYNAHAN, JUDGES.
MOYNAHAN, JUDGE: This is a medical negligence case. The Appellant,
Marion Gail Smith (“Smith”), appeals from a Fayette Circuit Court verdict and
judgment that held the Appellee, Dr. Belinda L. Shirkey, M.D. (“Shirkey”), did not
fail to meet her duty of care when she evaluated Smith for post-surgical complications. After careful review, we AFFIRM the verdict and judgment of the
Fayette Circuit Court.
BACKGROUND
Dr. Thomas Abell performed cataract removal surgery on Smith’s
right eye on May 17, 2021. During the operation he injected a steroid medication
into the eye to mitigate post-surgical swelling. On June 4, 2021, Smith visited Dr.
Abell’s office, complaining of worsening vision. Dr. Michael Tanner, an
ophthalmologist with Abell Eyes, examined her and, observing a slight elevation of
the retina, referred her to a same day appointment at Retina and Vitreous
Associates of Kentucky, PLLC (“RAK”). Dr. Tanner testified that there were no
holes or tears in Smith’s retina, and that he did not suspect a retinal detachment
(“RD”) on that day. However, RAK had more powerful imaging technology that
would provide a clearer look at the area with the anomaly. Dr. Tanner instructed
Smith to visit RAK for testing that afternoon and return to Abell Eyes in one week
for follow-up.
Shirkey, a physician with RAK, evaluated Smith on June 4, 2021.
After examination and imaging, Shirkey concluded that Smith’s visual issues
stemmed from residual effects of the surgical steroid injection and would resolve
as the drug dissolved within her eye. She testified that there was no tear or
detachment present on June 4, 2021. She further stated that Smith was temporarily
-2- at increased risk of RD due to her recent cataract surgery and needed regular
follow-up visits. Shirkey explained the elevated risk level to Smith and told her to
return in one week to be re-evaluated. Smith indicated that she preferred to stay
with Dr. Abell’s practice. Shirkey said that was fine but emphasized that Smith
had to be seen somewhere for follow-up in one week and would require close
monitoring while she continued to heal from the cataract surgery. Smith said she
would book an appointment with Abell Eyes the next morning. Shirkey told her
she was welcome to return to RAK at any time if she needed care, and the
appointment ended.
Smith did not return to either Dr. Abell’s office or to RAK in one
week. She returned to Dr. Abell’s office on June 23, 2021, more than two weeks
later, complaining of vision loss. Dr. Abell observed an RD and immediately
referred her to RAK. Dr. Blake Isernhagen of RAK ultimately performed a
successful re-attachment surgery. Although left with residual visual impairment,
Smith testified that she is still able to read, drive, travel, and perform the necessary
activities of daily living.
Smith filed a complaint for medical negligence that named both
Shirkey individually, and the entire RAK medical practice group collectively, as
defendants. She alleged that Shirkey failed to provide the appropriate standard of
-3- care to her when she did not diagnose an “impending” RD on June 4, 2021,
resulting in permanent visual impairment.
PROCEDURAL HISTORY
The case was tried before a jury in Fayette Circuit Court on
September 23-26, 2024. Ten jurors found that Shirkey did not fail to comply with
her duty of care when she evaluated Smith on June 4, 2021. Therefore, the circuit
court entered a Trial Verdict and Judgment in favor of Shirkey and RAK. No post-
trial motions were filed. Smith filed a Notice of Appeal with this Court on October
30, 2024.
STANDARD OF REVIEW
Smith asserts two separate issues on appeal. First, she argues that the
trial court issued erroneous jury instructions when it included the words
“vitreoretinal surgery” in an instruction. Second, she contends that the trial court
erred by excluding certain portions of Dr. Tanner’s testimony from jury
consideration.
Alleged errors in jury instructions are considered questions of law
which we review de novo. Perdue v. Commonwealth, 411 S.W.3d 786 (Ky. App.
2013). See also Howell v. Commonwealth, 296 S.W.3d 430, 432-33 (Ky. App.
2009) (citing Hamilton v. CSX Transportation, Inc., 208 S.W.3d 272, 275 (Ky.
-4- App. 2006), and Reece v. Dixie Warehouse and Cartage Co., 188 S.W.3d 440 (Ky.
App. 2006)).
We review a trial court’s decisions on the admission and exclusion of
evidence under an abuse of discretion standard. Clephas v. Garlock, Inc., 168
S.W.3d 389, 393 (Ky. App. 2004). Further, “[t]he test for abuse of discretion is
whether the trial judge’s decision was arbitrary, unreasonable, unfair, or
unsupported by sound legal principles.” Commonwealth v. English, 993 S.W.2d
941, 945 (Ky. 1999).
ANALYSIS
I. Jury Instruction
Smith requested the jury be instructed that Shirkey’s duty was to
exercise the level of care and skill expected of “a reasonably competent physician
specializing in ophthalmology and acting under the same or similar
circumstances.”
The actual jury instruction issued by the trial court reads: “It was the
duty of the Defendant Belinda L. Shirkey, M.D., when treating the Plaintiff Marion
Gail Smith, to exercise the degree of care and skill expected of a reasonably
competent physician specializing in ophthalmology and vitreoretinal surgery and
acting under the same or similar circumstances.” (Emphasis added.)
-5- Smith argues that holding Shirkey to any standard other than that of a
general ophthalmologist is inconsistent with American Board of Medical Licensure
standards and also unfairly led the jury to ascribe more expertise and credibility to
Shirkey, resulting in prejudicial error.
Interestingly, it is true that there is no formal board certification, or
any official specialty of practice designation, for retina-focused practitioners in the
United States. Several ophthalmologists testified, both in depositions and at trial,
that retina specialists typically complete a one-to-two-year fellowship beyond the
standard medical residency in ophthalmology. This means the standard of care for
an ophthalmologist specializing in retinal medicine and surgery is the same
standard of care as a general ophthalmologist who completed an ophthalmology
residency. Since board certification is not a possibility at present, there are no
established standards for consideration of post-residency specialty fellowships in
licensing or legal settings.
In Blair v.
Free access — add to your briefcase to read the full text and ask questions with AI
RENDERED: SEPTEMBER 5, 2025; 10:00 A.M. NOT TO BE PUBLISHED
Commonwealth of Kentucky Court of Appeals NO. 2024-CA-1304-MR
MARION GAIL SMITH APPELLANT
APPEAL FROM FAYETTE CIRCUIT COURT v. HONORABLE KIMBERLY N. BUNNELL, JUDGE ACTION NO. 22-CI-01381
BELINDA L. SHIRKEY, M.D. AND RETINA AND VITREOUS ASSOCIATES OF KENTUCKY, PLLC D/B/A RETINA ASSOCIATES OF KENTUCKY APPELLEES
OPINION AFFIRMING
** ** ** ** **
BEFORE: THOMPSON, CHIEF JUDGE; ACREE AND MOYNAHAN, JUDGES.
MOYNAHAN, JUDGE: This is a medical negligence case. The Appellant,
Marion Gail Smith (“Smith”), appeals from a Fayette Circuit Court verdict and
judgment that held the Appellee, Dr. Belinda L. Shirkey, M.D. (“Shirkey”), did not
fail to meet her duty of care when she evaluated Smith for post-surgical complications. After careful review, we AFFIRM the verdict and judgment of the
Fayette Circuit Court.
BACKGROUND
Dr. Thomas Abell performed cataract removal surgery on Smith’s
right eye on May 17, 2021. During the operation he injected a steroid medication
into the eye to mitigate post-surgical swelling. On June 4, 2021, Smith visited Dr.
Abell’s office, complaining of worsening vision. Dr. Michael Tanner, an
ophthalmologist with Abell Eyes, examined her and, observing a slight elevation of
the retina, referred her to a same day appointment at Retina and Vitreous
Associates of Kentucky, PLLC (“RAK”). Dr. Tanner testified that there were no
holes or tears in Smith’s retina, and that he did not suspect a retinal detachment
(“RD”) on that day. However, RAK had more powerful imaging technology that
would provide a clearer look at the area with the anomaly. Dr. Tanner instructed
Smith to visit RAK for testing that afternoon and return to Abell Eyes in one week
for follow-up.
Shirkey, a physician with RAK, evaluated Smith on June 4, 2021.
After examination and imaging, Shirkey concluded that Smith’s visual issues
stemmed from residual effects of the surgical steroid injection and would resolve
as the drug dissolved within her eye. She testified that there was no tear or
detachment present on June 4, 2021. She further stated that Smith was temporarily
-2- at increased risk of RD due to her recent cataract surgery and needed regular
follow-up visits. Shirkey explained the elevated risk level to Smith and told her to
return in one week to be re-evaluated. Smith indicated that she preferred to stay
with Dr. Abell’s practice. Shirkey said that was fine but emphasized that Smith
had to be seen somewhere for follow-up in one week and would require close
monitoring while she continued to heal from the cataract surgery. Smith said she
would book an appointment with Abell Eyes the next morning. Shirkey told her
she was welcome to return to RAK at any time if she needed care, and the
appointment ended.
Smith did not return to either Dr. Abell’s office or to RAK in one
week. She returned to Dr. Abell’s office on June 23, 2021, more than two weeks
later, complaining of vision loss. Dr. Abell observed an RD and immediately
referred her to RAK. Dr. Blake Isernhagen of RAK ultimately performed a
successful re-attachment surgery. Although left with residual visual impairment,
Smith testified that she is still able to read, drive, travel, and perform the necessary
activities of daily living.
Smith filed a complaint for medical negligence that named both
Shirkey individually, and the entire RAK medical practice group collectively, as
defendants. She alleged that Shirkey failed to provide the appropriate standard of
-3- care to her when she did not diagnose an “impending” RD on June 4, 2021,
resulting in permanent visual impairment.
PROCEDURAL HISTORY
The case was tried before a jury in Fayette Circuit Court on
September 23-26, 2024. Ten jurors found that Shirkey did not fail to comply with
her duty of care when she evaluated Smith on June 4, 2021. Therefore, the circuit
court entered a Trial Verdict and Judgment in favor of Shirkey and RAK. No post-
trial motions were filed. Smith filed a Notice of Appeal with this Court on October
30, 2024.
STANDARD OF REVIEW
Smith asserts two separate issues on appeal. First, she argues that the
trial court issued erroneous jury instructions when it included the words
“vitreoretinal surgery” in an instruction. Second, she contends that the trial court
erred by excluding certain portions of Dr. Tanner’s testimony from jury
consideration.
Alleged errors in jury instructions are considered questions of law
which we review de novo. Perdue v. Commonwealth, 411 S.W.3d 786 (Ky. App.
2013). See also Howell v. Commonwealth, 296 S.W.3d 430, 432-33 (Ky. App.
2009) (citing Hamilton v. CSX Transportation, Inc., 208 S.W.3d 272, 275 (Ky.
-4- App. 2006), and Reece v. Dixie Warehouse and Cartage Co., 188 S.W.3d 440 (Ky.
App. 2006)).
We review a trial court’s decisions on the admission and exclusion of
evidence under an abuse of discretion standard. Clephas v. Garlock, Inc., 168
S.W.3d 389, 393 (Ky. App. 2004). Further, “[t]he test for abuse of discretion is
whether the trial judge’s decision was arbitrary, unreasonable, unfair, or
unsupported by sound legal principles.” Commonwealth v. English, 993 S.W.2d
941, 945 (Ky. 1999).
ANALYSIS
I. Jury Instruction
Smith requested the jury be instructed that Shirkey’s duty was to
exercise the level of care and skill expected of “a reasonably competent physician
specializing in ophthalmology and acting under the same or similar
circumstances.”
The actual jury instruction issued by the trial court reads: “It was the
duty of the Defendant Belinda L. Shirkey, M.D., when treating the Plaintiff Marion
Gail Smith, to exercise the degree of care and skill expected of a reasonably
competent physician specializing in ophthalmology and vitreoretinal surgery and
acting under the same or similar circumstances.” (Emphasis added.)
-5- Smith argues that holding Shirkey to any standard other than that of a
general ophthalmologist is inconsistent with American Board of Medical Licensure
standards and also unfairly led the jury to ascribe more expertise and credibility to
Shirkey, resulting in prejudicial error.
Interestingly, it is true that there is no formal board certification, or
any official specialty of practice designation, for retina-focused practitioners in the
United States. Several ophthalmologists testified, both in depositions and at trial,
that retina specialists typically complete a one-to-two-year fellowship beyond the
standard medical residency in ophthalmology. This means the standard of care for
an ophthalmologist specializing in retinal medicine and surgery is the same
standard of care as a general ophthalmologist who completed an ophthalmology
residency. Since board certification is not a possibility at present, there are no
established standards for consideration of post-residency specialty fellowships in
licensing or legal settings.
In Blair v. Eblen, 461 S.W.2d 370, 373 (Ky. 1970), Kentucky’s then
highest court defined the medical standard of care as “a duty to use that degree of
care and skill which is expected of a reasonably competent pract[it]ioner in the
same class to which he belongs, acting in the same or similar circumstances.” The
Court further held: “we will leave determination of the standard to the medical
profession and not the lay courts.” Id.
-6- It is not wrong for a licensed ophthalmologist in good standing to
claim a specialty in vitreoretinal surgery if they are qualified to do so. However,
the medical licensure and certification agencies in this country do not currently
recognize this specialty. By including vitreoretinal surgery terminology in its
instruction, the trial court established a medical standard in the absence of any
guidance from the medical community, thereby failing to leave determination of
the proper standard to the medical profession as required by Blair.
Although we find the jury instruction technically inaccurate for this
reason, we do not agree that its inaccuracy results in reversible error. “The
purpose of instruction is to fairly present to the jury the legal issues involved.”
Cobb v. Hoskins, 554 S.W.2d 886, 887 (Ky. App. 1977). Nothing in this statement
of purpose demands absolute perfection in jury instructions. The error herein did
not affect the verdict, nor did it prevent the jury from fulfilling its fact-finding role.
The instruction, as written, held Shirkey to the same degree of care and skill
expected of a reasonably competent physician specializing in both ophthalmology
and vitreoretinal surgery, not a reasonably competent physician specializing in
ophthalmology or vitreoretinal surgery. Therefore, the jury was charged with
determining whether Shirkey met two standards of care. And, despite the lack of a
formal certification for vitreoretinal surgery, there is no doubt that including an
-7- additional practice area, especially a surgical specialty, resulted in Shirkey being
held to a higher standard than a general ophthalmologist.
Since Shirkey was found to have successfully met this arguably
elevated standard, it is illogical to argue that she would have failed to meet an
arguably lower one—the standard of care required of a reasonably competent
physician specializing in ophthalmology alone. Further, Smith’s complaint that the
instruction led the jury to extend Shirkey extra respect and credibility is also
unpersuasive. Shirkey testified at length about her education, qualifications, and
professional experience at trial, and her entire curriculum vitae was admitted into
evidence for the jury’s review. It seems unlikely the wording of a single jury
instruction would form the basis of the jury’s opinion after they had already been
privy to this in-depth information regarding Shirkey’s credentials. Smith failed to
establish the instruction as written was prejudicial to her case, and there is no
reasonable possibility that the inclusion of the words vitreoretinal surgery affected
the ultimate outcome of the case. Therefore, to the extent that the reference to
vitreoretinal surgery in the jury instruction constituted error, it was harmless.
II. Exclusion of Evidence
The trial court excluded limited portions of Dr. Tanner’s testimony
from jury consideration pursuant to Kentucky Rules of Evidence (“KRE”) 401 and
403. KRE 401 defines relevant evidence as “evidence having any tendency to
-8- make the existence of any fact that is of consequence to the determination of the
action more probable or less probable than it would be without the evidence.”
KRE 403 permits the exclusion of relevant evidence “if its probative value is
substantially outweighed by the danger of undue prejudice, confusion of the issues,
or misleading the jury, or by considerations of undue delay, or needless
presentation of cumulative evidence.”
The specific testimony excluded from trial pertained to Dr. Tanner’s
business relationships with Dr. Thomas Abell and the Abell Eyes and RAK
medical practice groups, as well as his participation in a pre-trial interview with
defense counsel. Smith argues that the jury should have had access to this
information because it called Dr. Tanner’s motives and credibility into question.
Dr. Tanner was initially hired by and worked for Dr. Abell. He later
bought, and currently owns, the Abell Eyes medical practice group, now called
Precision Eyes. He still practices ophthalmology there and routinely refers patients
with retina issues to RAK. He does not make referrals to specific physicians at
RAK but sends patients to whomever is available. Additionally, Dr. Tanner was
aware that Shirkey’s defense counsel represented Dr. Abell in a separate matter
and knew the attorney’s name. The trial court excluded Dr. Tanner’s testimony
about these facts from evidence. Smith claims that these facts constitute pre-
-9- existing relationships that invest Dr. Tanner in protecting Shirkey’s professional
reputation and cast doubt on his ability to testify truthfully about Smith’s case.
Abell Eyes and RAK are distinct business entities that do not share
office space, staff, resources, or funding sources. Dr. Tanner testified that the
relationships between himself, Abell Eyes, RAK, and the physicians and staff who
work for both groups are all business relationships, not personal in nature. In
response to a question from defense counsel, he agreed that it was important to
maintain a good working relationship between Abell Eyes and RAK. Smith
pointed to that answer as proof of Dr. Tanner’s biases and motivations, but that
statement is simply an acknowledgement of the business reality of practicing
medicine in a mid-size city. There are only two sizable retina practices in
Lexington: RAK and the University of Kentucky eye clinic; it would be routine
for Dr. Tanner to maintain good working relationships with both. Also, Abell
Eyes, as a general ophthalmology practice, typically refers patients to RAK, a
specialty practice. The opposite arrangement is far less common. Thus, there is no
evidence that Abell Eyes would sustain a marked decrease in business if one of
their doctors disagreed with an RAK doctor about a case. Finally, the fact that Dr.
Tanner remembered that Shirkey’s counsel had represented Dr. Abell in the past
does not appear particularly relevant. Dr. Abell was not a party to this action, he
did not testify for either side, and he no longer works with Dr. Tanner.
-10- Dr. Tanner enjoyed customary professional relationships with
colleagues, valued cordial working relationships with other medical practices, and
recalled that a local attorney had represented a former employer. Further, Smith
offered no evidence that a verdict against Shirkey would adversely affect Dr.
Tanner’s relationships with RAK, Dr. Abell, or any other coworker or colleague,
nor would it negatively impact Dr. Tanner’s own reputation or financial well-
being. Absent a more consequential degree of connection, these facts alone are not
particularly probative of bias on the part of Dr. Tanner.
Turning to Dr. Tanner’s pre-trial interview with Shirkey’s counsel, the
first fact to consider is that it was done in accordance with a Qualified HIPAA
Protective Order obtained from the trial court during discovery.1 The order
permitted Shirkey’s attorney to engage in limited ex parte discussions with Smith’s
treating physicians. It placed parameters on the use and dissemination of Smith’s
protected health information to preserve her privacy as much as possible while
facilitating pre-trial discovery.
Defense counsel contacted Dr. Tanner, informed him of the court
order, and asked if he would be willing to answer questions about his treatment of
Smith on June 4, 2021. Dr. Tanner agreed and spoke with defense counsel on one
occasion—without first consulting or advising Smith. During Dr. Tanner’s
1 See Qualified HIPAA Protective Order dated December 22, 2022.
-11- deposition, Smith’s counsel questioned him about this interaction and implied that
Dr. Tanner had acted unethically. The trial court excluded this portion of the
deposition. Smith argues that Dr. Tanner’s willingness to discuss her case without
her permission reflects on his credibility and was “essential” for the jury’s
Trial courts exercise broad discretion on evidentiary matters, and they
do so on a case-by-case basis. Under KRE 403, trial courts must balance the
probative value of contested evidence against any prejudice it may elicit. They
also must weigh the probative value of any evidence against its potential for
creating confusion or misleading the jury. “Confusion of the issues is generally
used to exclude evidence that creates side issues that distract jurors from the real
issues of the case.” Ten Broeck Dupont, Inc. v. Brooks, 283 S.W.3d 705, 715 (Ky.
2009) (internal quotation marks and citations omitted). “Misleading the jury refers
primarily to the possibility of the jury overvaluing the probative value of a
particular item of evidence for reasons other than the emotional reaction associated
with unfair prejudice.” Id. (internal quotation marks and citation omitted).
Here, while some of the excluded testimony might arguably have been
relevant as sources of potential bias on Dr. Tanner’s part, its inclusion could also
have confused or misled the jury. Dr. Tanner did have an ex parte conversation
with defense counsel about Smith’s care—but it was authorized by a court order.
-12- Suggesting this discussion between Dr. Tanner and defense counsel was somehow
nefarious risked confusing or misleading the jury in addition to being prejudicial to
Shirkey.
Similarly, Dr. Tanner did have long-standing business connections to
Dr. Abell and had some awareness of Dr. Abell’s involvement in an unrelated
lawsuit—where the latter was represented by Shirkey’s same counsel. But Dr.
Abell was a non-party in this lawsuit and was not called as a witness at trial. As
such, the probative value of this information involving Dr. Abell was limited
compared with its potential to create side issues that would “distract jurors from
the real issues of the case.” Brooks, 283 S.W.3d at 715. And while we
acknowledge another trial judge might have drawn the exclusion line on this
evidence in a different place, we cannot say the circuit court’s Rule 403 balancing
decision here was arbitrary, unreasonable, unfair, or unsupported by sound legal
principles.
CONCLUSION
For the reasons set forth above, the Fayette Circuit Court’s verdict and
judgment is hereby AFFIRMED.
ALL CONCUR.
-13- BRIEFS FOR APPELLANT: BRIEF FOR APPELLEES:
D. Seth Coomer Jonathan D. Weber Lexington, Kentucky Ellen L. Black Lexington, Kentucky
-14-